Skip to main content
Clinical Trials/NCT04367220
NCT04367220
Recruiting
Not Applicable

Cardiovascular Imaging Registry of Canada

University of Calgary4 sites in 1 country45,000 target enrollmentAugust 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular Diseases
Sponsor
University of Calgary
Enrollment
45000
Locations
4
Primary Endpoint
Malignant arrhythmic events
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

A multi-site, multi-modality prospective observational clinical outcomes study focussed on the development of phenotype-dirven risk prediction modelling in patients with known or suspected cardiovascular disease.

Detailed Description

The Cardiovascular Imaging Registry of Canada (CIROC) was conceived to provide a common standardized architecture for the collection of clinically reported imaging biomarkers, demographic information, resource utilization and clinical outcomes among patients referred to non-invasive cardiac imaging. The Registry was designed to assess the feasibility of implementing personalized care strategies through automated high quality data collection and patient engagement. The CIROC Registry was launched with inaugural focus on Cardiac MRI base phenotyping, however has evolved to encompass cardiac CTA and echocardiography. Clinically referred patients are engaged by automated, tablet-based tools to collect informed consent and deploy standardized patient health assessments. Standardized reporting of disease features are captured using bespoke reporting tools. All patients are prospectively followed for a period of 10-years using linkage to administrative health data, inclusive of ICD-coded events, laboratory test results, ECG and vital statistics.

Registry
clinicaltrials.gov
Start Date
August 2014
End Date
August 2030
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

James White

MD, FRCP(C) Director - Stephenson Cardiac Imaging Centre

University of Calgary

Eligibility Criteria

Inclusion Criteria

  • All patients referred for hospital-based cardiac imaging services

Exclusion Criteria

  • Failure or provide informed consent

Outcomes

Primary Outcomes

Malignant arrhythmic events

Time Frame: 2024

Composite of sudden cardiac death or appropriate ICD shock

Heart failure events

Time Frame: 2024

Composite of heart failure admission, death or need for transplantation / LVAD

Atrial arrhythmic events

Time Frame: 2024

Occurrence of atrial fibrillation / atrial flutter (documented by 12-lead ECG or Holter monitor)

Major adverse cardiovascular outcomes (MACE)

Time Frame: 2024

Composite of all-cause death, heart failure admission, myocardial infarction, heart transplantation or LVAD, Stroke or TIA

All-cause mortality

Time Frame: 2024

Death based on Vital Statistics Alberta and In-hospital coded death

Study Sites (4)

Loading locations...

Similar Trials